← Back to headlines
MiNK Therapeutics Reports GAAP EPS Beat at -$0.56
MiNK Therapeutics announced its GAAP EPS of -$0.56, beating analyst estimates by $0.12.
31 Mar, 11:34 — 31 Mar, 11:34
Sources
Showing 1 of 1 sources
Related Stories
Corporate Dividend Declarations Include Nvidia, Mosaic, and Alamos Gold
22m ago
Build-A-Bear Slashes Revenue Forecast and Replaces Executive After Summer Sales Miss
22m ago
Major Canadian Banks Report Strong Third-Quarter Earnings, Beating Forecasts
48m ago
Anthropic Introduces Framework for AI Agents to Control Physical Devices
1h ago